Genomic diversity in low-risk disease: present and future

Vidit Sharma, R. Jeffrey Karnes

Research output: Contribution to journalComment/debatepeer-review


New data have confirmed the genomic diversity of low-risk prostate cancer. Improved understanding of the heterogeneity of this disease has implications for disease management and has the potential to change treatment for patients in the future.

Original languageEnglish (US)
Pages (from-to)594-596
Number of pages3
JournalNature Reviews Urology
Issue number10
StatePublished - Oct 1 2018

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'Genomic diversity in low-risk disease: present and future'. Together they form a unique fingerprint.

Cite this